Chemokine receptor 9 (CCR9) polymorphisms: Susceptibility genes for inflammatory small bowel disease?

被引：0
|
作者：
McGovern, DP
Van Heel, D
Dechairo, B
Ahmad, T
Lench, N
Anderson, R
Jewell, D
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
M1442
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [21] Intracellular allosteric antagonism of the CCR9 receptor
    Oswald, Christine
    Rappas, Mathieu
    Kean, James
    Dore, Andrew S.
    Errey, James C.
    Bennett, Kirstie
    Eflorian, Francesca D.
    Christopher, John A.
    Jazayeri, Ali
    Mason, Jonathan S.
    Congreve, Miles
    Cooke, Robert M.
    Marshall, Fiona H.
    NATURE, 2016, 540 (7633) : 462 - +
  • [22] Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells
    Heinrich, Eileen L.
    Arrington, Amanda K.
    Ko, Michelle E.
    Luu, Carrie
    Lee, Wendy
    Lu, Jianming
    Kim, Joseph
    CANCER MICROENVIRONMENT, 2013, 6 (03) : 241 - 245
  • [23] Imaging of CCR9 in the small bowel of patients with Crohn's disease: effects of the CCR9-depleting monoclonal antibody AZD7798
    Hedin, C. R.
    Creignou, M.
    Mackay, J.
    Jucaite, A.
    Cselenyi, Z.
    Johnstrom, P.
    Dahl, K.
    Schou, M.
    Cortes Gonzalez, M. A.
    Hognasbacka, A.
    Stenkrona, P.
    Blomqvist, L. K.
    Cananau, C.
    Palmer, E.
    Bouma, G.
    Eck, S.
    Lund, J.
    Lundahl, A.
    Kiraga, J.
    Popinska, A.
    Eberhardson, M.
    Belvisi, M. G.
    Marks, D. J. B.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2052 - i2053
  • [24] Intracellular allosteric antagonism of the CCR9 receptor
    Christine Oswald
    Mathieu Rappas
    James Kean
    Andrew S. Doré
    James C. Errey
    Kirstie Bennett
    Francesca Deflorian
    John A. Christopher
    Ali Jazayeri
    Jonathan S. Mason
    Miles Congreve
    Robert M. Cooke
    Fiona H. Marshall
    Nature, 2016, 540 : 462 - 465
  • [25] Pharmacological Inhibition of C-C Chemokine Receptor 9 (CCR9) Does Not Inhibit the Generation of Oral Tolerance
    Walters, Matthew
    Ebsworth, Karen
    Sullivan, Tim
    Jaen, Juan
    Schall, Thomas
    GASTROENTEROLOGY, 2012, 142 (05) : S886 - S886
  • [26] CCX507, an Orally Bioavailable Antagonist of the Chemokine Receptor CCR9, for the Treatment of IBD
    Walters, Matthew
    Ebsworth, Karen
    Sullivan, Tim
    Zhang, Penglie
    Powers, Jay
    Bekker, Pirow
    Dairaghi, Daniel
    Seitz, Lisa
    Ertl, Linda
    Jaen, Juan
    Schall, Thomas
    GASTROENTEROLOGY, 2013, 144 (05) : S815 - S815
  • [27] Novel chemokine receptor 9 polymorphisms: Candidate genes for Crohn's disease (CD)?
    McGovern, DPB
    van Heel, DA
    Dechairo, B
    Ahmad, T
    Lench, NJ
    Jewell, DP
    GUT, 2001, 48 : A84 - A84
  • [28] Strong Expression of Chemokine Receptor CCR9 in B-Cell Lymphomas Involving the Gastrointestinal Tract
    Wu, W.
    Ngan, Dy
    Pullarkat, S. T.
    LABORATORY INVESTIGATION, 2012, 92 : 381A - 381A
  • [29] Strong Expression of Chemokine Receptor CCR9 in B-Cell Lymphomas Involving the Gastrointestinal Tract
    Wu, W.
    Ngan, D. Y.
    Pullarkat, S. T.
    MODERN PATHOLOGY, 2012, 25 : 381A - 381A
  • [30] The Chemokine Receptor CCR9 Is Required for the T-Cell-Mediated Regulation of Chronic Ileitis in Mice
    Wermers, Joshua D.
    McNamee, Eoin N.
    Wurbel, Marc-Andre
    Jedlicka, Paul
    Rivera-Nieves, Jesus
    GASTROENTEROLOGY, 2011, 140 (05) : 1526 - U214
12345